ORIGINAL ARTICLE
Year : 2016 | Volume
: 12 | Issue : 8 | Page : 260--263
Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer: A meta-analysis
Hongyuan Wang, Junfeng Qian
Department of Respiratory, The People's Hospital of Lishui, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, Zhejiang, China
Correspondence Address:
Junfeng Qian
Department of Respiratory, The People's Hospital of Lishui, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, Zhejiang
China
Objective: The purpose of this study was to assess the diagnostic sensitivity and specificity for serum pro-gastrin-releasing peptide (Pro-GRP) in diagnosis of small cell lung cancer (SCLC) through pooling all the open published data.
Materials and Methods: Databases of PubMed, Cochrane, ISI Web of Knowledge, and CNKI were electronic, searched by two reviewers to find the diagnostic study serum Pro-GRP in diagnosis of SCLC. The diagnostic sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the receiver operating characteristic (ROC) were calculated by Med DiSc1.4 software.
Results: Finally, 21 studies were included in this meta-analysis. Because of statistical heterogeneity, the specificity, specificity, positive/negative likelihood ratio, and DOR were pooled by random effect model. The pooled sensitivity, specificity, PLR, NLR, DOR, and area under the ROC were 64% (95% confidence interval [CI]: 62%–66%), 94% (95% CI: 94%–95%), 11.87% (95% CI: 8.62–11.35), 0.32% (95% CI: 0.26%–0.39%), 40.98% (95% CI: 27.77%–60.64%), and 0.94 (95% CI: 0.91%–0.96%).
Conclusion: Serum Pro-GRP was promising biomarker for SCLC diagnosis.
How to cite this article:
Wang H, Qian J. Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer: A meta-analysis.J Can Res Ther 2016;12:260-263
|
How to cite this URL:
Wang H, Qian J. Serum pro-gastrin-releasing peptide in diagnosis of small cell lung cancer: A meta-analysis. J Can Res Ther [serial online] 2016 [cited 2022 Jun 30 ];12:260-263
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2016;volume=12;issue=8;spage=260;epage=263;aulast=Wang;type=0 |
|
|
|
